Today, I review and link to Practical Neurology‘s Podcast: “The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease”.
Practical Neurology is a journal from BMJ, publishing articles of practical value to clinical neurologists
Practical Neurology is an international, peer-reviewed journal that is useful for everyone who sees neurological patients and who wants to keep up to date, and safe, in managing them. This is a journal for jobbing neurologists who plough through the tension headaches and funny turns week in and week out. Practical Neurology is available to all subscribers to JNNP.
Practical Neurology adheres to the highest possible industry standards concerning publication ethics. To read the journal’s detailed guidelines please see our policies.
Practical Neurology is the official journal of the Association of British Neurologists (ABN).
The journal publishes regular podcasts* of interviews with the authors of highlighted papers. Subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
*These podcasts are available to everyone, I believe.
The speaker says that they hope to have the timeline completed by the end of 2025 and to have the first visits starting May 2026. They will be updating their progress on benfotamine.org.
All that follows is from the Practical Neurology Podcast above. 11-19-2024.
Alzheimer Disease & Dementia
11.19.24
Podcast: Potential Therapy for Early Alzheimer Disease
Gary E. Gibson, PhDGary E. Gibson, PhD, Professor of Neurosciences, Burke Neurological Institute, Weill Cornell Medicine, White Plains, NY, details his research related to metabolic changes associated with Alzheimer disease and a clinical trial studying the effects of benfotiamine therapy on cognitive and other outcomes.
